4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001231615-25-000006
Director sold 60,000 shares at an average $121.72 ($7,303,400)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
JEFFS ROGER · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-27 | Sale : show line 1 in the form 10b5-1 | −20,000 | $122.30 | $2,446,000 | 110,974 | D |
| 2025-08-28 | Sale : show line 2 in the form 10b5-1 | −20,000 | $121.60 | $2,432,000 | 90,974 | D |
| 2025-08-29 | Sale : show line 3 in the form 10b5-1 | −20,000 | $121.27 | $2,425,400 | 70,974 | D |
| Open-market sales · 60,000 sh · avg $121.72 · $7,303,400 | ||||||
Loading xslF345X05/ownership.xml…